Could ginger and perilla replace acid pills for stomach trouble?

NCT ID NCT07655219

Not yet recruiting Symptom relief Sponsor: Liaquat University of Medical & Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a dietary supplement made from ginger and perilla (Dispepril®) can improve stomach symptoms in people with functional dyspepsia, a condition causing fullness, bloating, and pain after eating. 400 adults will be randomly assigned to take the supplement alone, the supplement plus a half-dose acid-reducing drug, or a full-dose acid-reducing drug for 14 days. The goal is to see if the supplement works as well as standard treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ginger and perilla extract supplement (Dispepril®)
What this could lead to: If it works, this could offer a natural alternative to acid-reducing drugs for people with chronic indigestion.
What could go wrong: This is a small, early-stage trial with only 14 days of treatment. The supplement may not work better than standard drugs, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dyspepsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FUNCTIONAL DYSPHONIA

Contacts and locations

Locations

Gastroenterology Centre

Salerno, Italy
U.O.S.D. Digestive Endoscopy, Interventional and Emergency Unit

Montevarchi, Italy
University of Rome Tor Vergata

Rome, Italy
University of Urbino Carlo Bo

Urbino, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.